Sartorius Stedim stock trades at EUR 210.10, 6.6 percent below its high

Published on 10/09/2026 at 15:10 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Sartorius Stedim stock costs EUR 210.10 on October 9, 2026, plus 0.57 percent versus EUR 208.90. Its high is EUR 225.00.

Key points in brief

Sartorius Stedim stock was at EUR 210.10 at Lang & Schwarz on October 9, 2026, plus 0.57 percent versus EUR 208.90.
The price stood 6.62 percent below its EUR 225.00 52-week high, with a EUR 20.4 billion market capitalization and a P/E ratio of 69.93.
AlphaValue/Baader Europe raised its price target to EUR 253, while Sartorius Stedim schedules its 9M 2026 results conference call for October 22, 2026.

Isometrische Prozessdarstellung einer Bioprozess-Wertschöpfungskette von Zellkultur bis Abfüllung — Sartorius Stedim Biotech isometrisches 3D-Diagramm der Bioprozess-Wertschöpfungskette von Zellkultur bis Abfüllung, ISIN FR0013154002, Illustration mit AI erstellt.

Sartorius Stedim stock (ISIN FR0013154002) was trading at EUR 210.10 at Lang & Schwarz on October 9, 2026 at 3:04 p.m. CEST, plus 0.57 percent versus the prior close of EUR 208.90. The modest move leaves the share 6.62 percent below its EUR 225.00 52-week high.

Volume stays below average

Trading volume stood at 15,910 shares on October 9, 2026 at 2:53 p.m. CEST, compared with an average volume of 90,381 shares. The gap places the session activity below its recent average while the Lang & Schwarz quote remains above the primary-market quote of EUR 209.60 at the same timestamp.

Range and valuation

The 52-week range runs from EUR 150.00 to EUR 225.00 as of October 9, 2026. At EUR 210.10, the stock is 6.62 percent below the upper end and 40.07 percent above the lower end of that range.

Sartorius Stedim had a market capitalization of EUR 20.4 billion and a P/E ratio of 69.93 on October 9, 2026. Finimize reports that AlphaValue/Baader Europe raised its price target to EUR 253 while cutting its 2026 and 2027 earnings forecasts by 9.20 percent. The target lies 20.42 percent above the Lang & Schwarz price.

Comparison with peers

Sartorius Stedim (Euronext Paris, EUR, October 9, 2026): plus 0.57 percent, P/E 69.93, market capitalization EUR 20.4 billion
Thermo Fisher Scientific (NYSE, USD, October 8, 2026): minus 1.52 percent, P/E 35.07, market capitalization USD 241.1 billion
Danaher (NYSE, USD, October 8, 2026): minus 0.47 percent, P/E 38.63, market capitalization USD 152.9 billion

Next results date is October 22

Sartorius Stedim schedules its conference call for the nine-month 2026 results for October 22, 2026 at 1:00 p.m. CEST. The date gives the valuation figures a defined near-term reporting point, while the current quote remains 6.62 percent below the annual high.

Market context and quote

On October 9, 2026, the stock was trading at EUR 210.10 at Lang & Schwarz at 3:04 p.m. CEST, compared with the EUR 208.90 prior close from October 8, 2026. Its EUR 20.4 billion market capitalization places the company below the two US peers in absolute value, while its P/E ratio of 69.93 is higher than both peer readings.

The further course of trading is shown by the continuously updated real-time quote of Sartorius Stedim stock.